Emergent BioSolutions
EBS
$8.87
Share price
-2.79%
Change (1 day)
133.19%
Change (1 year)
Categories
Emergent BioSolutions (EBS) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : A$1.44 Billion
According to Emergent BioSolutions 's latest financial reports the company's total liabilities are A$1.44 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | A$1.45 B | -15.38% |
| 2023-12-31 | A$1.72 B | -34.08% |
| 2022-12-31 | A$2.61 B | 40.76% |
| 2021-12-31 | A$1.85 B | -0.58% |
| 2020-12-31 | A$1.86 B | 5.56% |
| 2019-12-31 | A$1.76 B | 2.3% |
| 2018-12-31 | A$1.72 B | 755.19% |
| 2017-12-31 | A$0.20 B | -61.01% |
| 2016-12-31 | A$0.51 B | 0.11% |
| 2015-12-31 | A$0.51 B | 10% |
| 2014-12-31 | A$0.47 B | 205.64% |
| 2013-12-31 | A$0.15 B | 31.16% |
| 2012-12-31 | A$0.11 B | -7.42% |
| 2011-12-31 | A$0.12 B | 1.71% |
| 2010-12-31 | A$0.12 B | 11.13% |
| 2009-12-31 | A$0.11 B | -13.36% |
| 2008-12-31 | A$0.12 B | 10.71% |
| 2007-12-31 | A$0.11 B | -7.52% |
| 2006-12-31 | A$0.12 B | 128.15% |
| 2005-12-31 | A$55.48 M | -6.88% |
| 2004-12-31 | A$59.58 M | |
| 2002-12-31 | A$33.07 M | -70.75% |
| 2001-12-31 | A$0.11 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | A$112.65 B | 7,699.54% | 🇺🇸 USA |
 | A$41.26 M | -97.14% | 🇺🇸 USA |
 | A$92.69 B | 6,317.36% | 🇬🇧 UK |
 | A$72.2 M | -95.00% | 🇺🇸 USA |
 | A$198.92 B | 13,672.08% | 🇺🇸 USA |
 | A$53.52 B | 3,605.59% | 🇮🇱 Israel |
 | A$7.23 M | -99.50% | 🇺🇸 USA |